Healthcare companies with the highest operating cash flow — page 2

Ranks 101–200 of 244 · Fiscal year 2025 · Data as of September 25, 2026

Operating cash flow
#CompanyOperating cash flowYoY15-year trend
101Collegium PharmaceuticalCOLLUS$329M+60.7%
102Stevanato GroupSTVNIT$323M+91.7%
103Hims & Hers HealthHIMSUS$300M+19.5%
104RadnetRDNTUS$299M+28.2%
105Merit Medical SystemsMMSIUS$297M+34.7%
106Teladoc HealthTDOCUS$294M+0.2%
107HaemoneticsHAEUS$293M+61.4%
108Bio-TechneTECHUS$288M−3.8%
109Sotera HealthSHCUS$287M+28.1%
110Bausch & LombBLCOCA$283M+22.0%
111Concentra Group Holdings ParentCONUS$279M+1.7%
112Envista HoldingsNVSTUS$276M−18.1%
113Surgery PartnersSGRYUS$274M−8.6%
114Trulieve CannabisTRLVUS$273M+0.5%
115Pediatrix MedicalMDUS$271M+31.2%
116Option Care HealthOPCHUS$258M−20.1%
117Prestige Consumer HealthcarePBHUS$258M+2.4%
118LivanovaLIVNGB$254M+39.0%
119PenumbraPENUS$239M+41.7%
120Kindercare Learning CompaniesKLCUS$239M+105.8%
121PerrigoPRGOIE$239M−34.3%
122Dentsply SironaXRAYUS$235M−49.0%
123Brookdale Senior LivingBKDUS$218M+31.2%
124EnovisENOVUS$217M+91.4%
125NateraNTRAUS$215M+58.7%
126ProgynyPGNYUS$210M+17.4%
127Catalyst PharmaceuticalsCPRXUS$209M−13.0%
128Krystal BiotechKRYSUS$201M+62.7%
129InnovivaINVAUS$197M+4.4%
130Integer HoldingsITGRUS$196M−4.4%
131Transmedics GroupTMDXUS$193M+295.1%
132EmbectaEMBCUS$192M+437.0%
133Ani PharmaceuticalsANIPUS$185M+189.3%
134National HealthcareNHCUS$185M+72.5%
135Icu MedicalICUIUS$180M−11.9%
136Arrowhead PharmaceuticalsARWRUS$180M+$642M
137CormedixCRMDUS$175M+$226M
138ConmedCNMDUS$171M+2.2%
139Emergent BiosolutionsEBSUS$171M+190.6%
140Privia HealthPRVAUS$163M+49.5%
141Amphastar PharmaceuticalsAMPHUS$156M−26.8%
142Pacira BiosciencesPCRXUS$152M−19.7%
143National VisionEYEUS$146M+9.5%
144Lifestance HealthLFSTUS$146M+36.3%
145Healthcare ServicesHCSGUS$145M+370.6%
146Corcept TherapeuticsCORTUS$142M−28.4%
147Alignment HealthcareALHCUS$140M+302.4%
148Kiniksa Pharmaceuticals InternationalKNSAGB$138M+437.1%
149Curaleaf HoldingsCURLFUS$138M−15.8%
150VeracyteVCYTUS$136M+81.5%
151Aurinia PharmaceuticalsAUPHCA$136M+205.6%
152Acadia HealthcareACHCUS$132M+1.7%
153Ironwood PharmaceuticalsIRWDUS$127M+22.7%
154Aveanna HealthcareAVAHUS$126M+285.6%
155RepligenRGENUS$117M−33.1%
156Inspire Medical SystemsINSPUS$117M−10.2%
157Fortrea HoldingsFTREUS$114M−56.8%
158Addus HomecareADUSUS$112M−4.2%
159Warby ParkerWRBYUS$111M+12.2%
160Acadia PharmaceuticalsACADUS$110M−30.4%
161Keros TherapeuticsKROSUS$108M+$268M
162QuidelorthoQDELUS$105M+26.7%
163Guardian Pharmacy ServicesGRDNUS$100M+73.0%
164TeleflexTFXUS$96.7M−68.0%
165Ufp TechnologiesUFPTUS$91.9M+38.0%
166TrupanionTRUPUS$89.5M+85.3%
167InmodeINMDIL$85.3M−35.7%
168NeogenNEOGUS$83.2M+43.0%
169Caris Life SciencesCAIUS$83.2M+$328M
170Lemaitre VascularLMATUS$81.3M+84.1%
171Irhythm HoldingsIRTCUS$80.9M+2,285.3%
172Nu Skin EnterprisesNUSUS$80.3M−28.2%
173Phibro Animal HealthPAHCUS$80.1M−8.5%
174Rigel PharmaceuticalsRIGLUS$75.7M+140.4%
175U S Physical TherapyUSPHUS$75.1M+0.2%
176Avanos MedicalAVNSUS$74.7M−25.8%
177BioventusBVSUS$74.7M+92.5%
178Mimedx GroupMDXGUS$74.0M+11.8%
179Cresco LabsCRLBFUS$72.9M−45.0%
180Akebia TherapeuticsAKBAUS$68.0M+$109M
181Porch GroupPRCHUS$66.4M+$98.1M
182Castle BiosciencesCSTLUS$64.3M−0.8%
183Cadre HoldingsCDREUS$63.7M+100.5%
184Ascendis PharmaASNDDK$60.9M+$392M
185AtricureATRCUS$57.3M+369.8%
186Mirum PharmaceuticalsMIRMUS$55.8M+440.7%
187Pharming GroupPHARNL$54.7M+$56.5M
188Viemed HealthcareVMDUS$51.9M+32.8%
189VericelVCELUS$51.9M−10.8%
190SNDLSNDLCA$50.8M+26.6%
191Adma BiologicsADMAUS$50.4M−57.5%
192Integra LifesciencesIARTUS$50.4M−61.1%
193Ligand PharmaceuticalsLGNDUS$49.4M−49.1%
194Pennant GroupPNTGUS$48.3M+22.9%
195Supernus PharmaceuticalsSUPNUS$47.3M−72.5%
196Stoke TherapeuticsSTOKUS$45.6M+$132M
197Alphatec HoldingsATECUS$45.2M+$89.9M
198HarrowHROWUS$43.9M+$66.1M
199Tactile Systems TechnologyTCMDUS$42.8M+5.3%
200CaredxCDNAUS$42.0M+10.5%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Companies with the highest operating cash flow →

By sector

By country